Cancellation of state registration. Synakten Depot

January 13, 2017
Active substances:
Trade names:
ICD-10:
VI.G35-G37.G35    Multiple sclerosis
XI.K50-K52.K51    Ulcerative colitis
XI.K50-K52.K52    Other non-infectious gastroenteritis and colitis
XII.L10-L14.L10    Pemphigus [pemphigus]
XII.L20-L30.L20.8    Other atopic dermatitis
XII.L40-L45.L40    Psoriasis
XIV.N00-N08.N04    Nephrotic syndrome
XXI.Z00-Z13.Z03    Medical surveillance and evaluation in case of suspected disease or pathological condition
Sinacten depot, tetracosactide, multiple sclerosis, ulcerative colitis, pemphigus, atopic dermatitis, psoriasis, improvement of chemotherapy tolerance

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N013438 / 01 dated 23.12.2011, issued by the Operations and Kvestkor Limited, Ireland):

Sinakten Depot (trade name of the medicinal product)

Tetracosactide (international non-proprietary or grouping or chemical name)

suspension for intramuscular injection, 1 mg / ml (dosage form, dosage)

QuestCorruption Limited, Ireland Sandyford Business Center, Unit 7, Dublin 18, Ireland (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by an authorized legal entity LLC "TransLit" application for the abolition of state registration of a medicinal product.